BUY Sun Pharmaceutical Industries Ltd. — Kunal Parar, Choice Broking
byKunal Parar, Choice BrokingHorizon: NA (inferred Swing (≤2wk))3 Jul 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
4 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·15 Jul · yesterday
Sun Pharmaceutical Industries Limited has received approval to manufacture and market a generic version of semaglutide in South Africa, expanding its product portfolio and market access.
NSE · Press Release·15 Jul · 2d ago
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·13 Jul · 4d ago
Sun Pharma has entered into an agreement to acquire 100% outstanding shares of Innovcare Lifesciences Private Limited for approximately Rs 271.2 Crores. Innovcare is engaged in marketing, distribution
BSE · Company Update·20 Jun · 4w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.